NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that Chairman Randal J. Kirk and Meeta Patnaik, Senior Vice President of PGxHealth, will present at The Society of Experimental Biology and Medicine’s symposium: Progress in Pharmacogenomics and Its Promise for Medicine from 3:15 p.m. to 5:15 p.m. Sunday, April 6, 2008 at the San Diego Convention Center, Ballroom 20A, at 111 West Harbor Drive. Clinical Data’s PGxHealth division focuses on the use of genetic biomarkers associated with drug response to guide physicians and patients to the drug or drug class that is most likely to be effective. The session will be co-chaired by Clinical Data, Inc. board member Burton E. Sobel of the University of Vermont.
